[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Tenax Therapeutics (TENX)

Tenax Therapeutics (TENX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 314,852
  • Shares Outstanding, K 26,525
  • Annual Sales, $ 0 K
  • Annual Income, $ -52,600 K
  • EBIT $ -62 M
  • EBITDA $ -62 M
  • 60-Month Beta 1.00
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 2.47

Options Overview Details

View History
  • Implied Volatility 105.20% (+9.65%)
  • Historical Volatility 61.24%
  • IV Percentile 65%
  • IV Rank 18.73%
  • IV High 236.76% on 03/25/26
  • IV Low 74.89% on 05/15/26
  • Expected Move (DTE 18) 1.53 (12.89%)
  • Put/Call Vol Ratio 0.78
  • Today's Volume 903
  • Volume Avg (30-Day) 415
  • Put/Call OI Ratio 0.23
  • Today's Open Interest 9,431
  • Open Int (30-Day) 6,622
  • Expected Range 10.34 to 13.40

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 8 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/26
See More
  • Average Estimate $-0.40
  • Number of Estimates 4
  • High Estimate $-0.34
  • Low Estimate $-0.45
  • Prior Year $-0.27
  • Growth Rate Est. (year over year) -48.15%

Price Performance

See More
Period Period Low Period High Performance
1-Month
10.95 +8.40%
on 05/19/26
13.73 -13.55%
on 04/30/26
-0.91 (-7.12%)
since 04/29/26
3-Month
10.37 +14.46%
on 03/09/26
16.95 -29.97%
on 04/01/26
-0.13 (-1.08%)
since 02/27/26
52-Week
5.34 +122.28%
on 06/20/25
18.38 -35.42%
on 01/14/26
+5.80 (+95.55%)
since 05/28/25

Most Recent Stories

More News
Tenax Therapeutics: Q1 Earnings Snapshot

Tenax Therapeutics: Q1 Earnings Snapshot

TENX : 11.87 (+1.54%)
Tenax Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update

On track to report topline data from Phase 3 LEVEL study of TNX-103 in third quarter of 2026 Global Phase 3 LEVEL-2 clinical trial ongoing, enrollment completion anticipated by end of 2027 Strengthened...

TENX : 11.87 (+1.54%)
Tenax Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

CHAPEL HILL, N.C., May 08, 2026 (GLOBE NEWSWIRE) -- Tenax Therapeutics, Inc. (Nasdaq: TENX) (“Tenax” or “Tenax Therapeutics” or the “Company”), a Phase 3, development-stage pharmaceutical...

TENX : 11.87 (+1.54%)
Tenax Therapeutics Appoints Timothy Healey, MBA as Chief Commercial Officer

CHAPEL HILL, N.C., May 04, 2026 (GLOBE NEWSWIRE) -- Tenax Therapeutics, Inc. (Nasdaq: TENX) (“Tenax” or “Tenax Therapeutics” or the “Company”), a Phase 3, development-stage pharmaceutical...

TENX : 11.87 (+1.54%)
Tenax Therapeutics Appoints Thomas R. Staab, II as Chief Financial Officer

Mr. Staab has over 25 years of financial and executive experience across the healthcare industry CHAPEL HILL, N.C., April 22, 2026 (GLOBE NEWSWIRE) -- Tenax Therapeutics, Inc. (Nasdaq: TENX) (“Tenax”...

TENX : 11.87 (+1.54%)
Tenax Therapeutics: Q4 Earnings Snapshot

Tenax Therapeutics: Q4 Earnings Snapshot

TENX : 11.87 (+1.54%)
Tenax Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update

Achieved randomization target of 230 patients in LEVEL study, topline data expected in third quarter of 2026 Initiated global Phase 3 LEVEL-2 clinical trial and opened long-term OLE study for patients...

TENX : 11.87 (+1.54%)
Tenax Therapeutics to Participate in the 2026 Leerink Partners Global Healthcare Conference

CHAPEL HILL, N.C., March 03, 2026 (GLOBE NEWSWIRE) -- Tenax Therapeutics, Inc. (Nasdaq: TENX) (“Tenax” or “Tenax Therapeutics” or the “Company”), a Phase 3, development-stage pharmaceutical...

TENX : 11.87 (+1.54%)
Tenax Therapeutics to Participate in the Guggenheim Emerging Outlook Biotech Summit 2026

CHAPEL HILL, N.C., Feb. 04, 2026 (GLOBE NEWSWIRE) -- Tenax Therapeutics, Inc. (Nasdaq: TENX) (“Tenax” or “Tenax Therapeutics” or the “Company”), a Phase 3, development-stage pharmaceutical...

TENX : 11.87 (+1.54%)
Tenax Therapeutics Announces Result of Prespecifed Blinded Sample Size Assessment

Planned Review of Standard Deviation Demonstrates No Need to Increase Size of Ongoing LEVEL Study LEVEL On Track to Complete Enrollment in First Half of 2026; Topline Data Expected in Second Half...

TENX : 11.87 (+1.54%)

Business Summary

Tenax Therapeutics, Inc. is a specialty pharmaceutical company focused on developing and commercializing a portfolio of products for the critical care market. The Company specializes in creating pharmaceuticals and medical devices in the fields of oxygen therapeutics, blood substitutes, and liquid ventilation...

See More

Key Turning Points

3rd Resistance Point 12.60
2nd Resistance Point 12.28
1st Resistance Point 12.07
Last Price 11.87
1st Support Level 11.54
2nd Support Level 11.22
3rd Support Level 11.01

See More

52-Week High 18.38
Fibonacci 61.8% 13.40
Last Price 11.87
Fibonacci 50% 11.86
Fibonacci 38.2% 10.32
52-Week Low 5.34

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.